Put in this context, the blockade of the route of ghrelin could prove useful in controlling adiposity in human obesity, as blockers of the orexigenic signal from the gastrointestinal tract to the brain, or diminishing the ability to efficiently store fat reserves. The gene discussed is GHRL; the disease is obesity disorder.